Among these types of breast cancer, ER−/HER2− breast cancer, also known as triple-negative breast cancer (TNBC), because of the lack of ERα, PR, and ERBB2 expression, is the most aggressive subtype with advanced histological grade and poor clinical outcome despite appropriate treatment [3]. The gene discussed is ERBB2; the disease is breast carcinoma.